数字诊断：IVD 的前进之路（英）

330

数字诊断：IVD 的前进之路（英）

# 数字诊断 # 临床化学 # 卫生系统大小：0.64M | 页数：7 | 上架时间：2024-01-10 | 语言：英文

麦肯锡-数字诊断：IVD 的前进之路（英）.pdf

免费阅读3页，购买之后可查看、下载7页完整报告

麦肯锡-数字诊断：IVD 的前进之路（英）.pdf

试看3页

类型: 行研

上传者: 谢文晓

撰写机构: 麦肯锡

出版日期: 2024-01-10

摘要：

Growth is slowing in the diagnostics industry as historically unmet demand is being met. This is particularly true in areas such as hematology, clinical chemistry, and immunoassays. Over the past decade, for instance, the price of next-generation sequencing has decreased roughly 100-fold.1 At the same time, new lower-cost players are entering the market, and the consolidation of health systems and group purchasing organizations is driving down net prices (see sidebar, “Current trends in diagnostics”).2 Thus, for in vitro diagnostics (IVD) players, simply having a test is no longer sufficient. It’s incumbent on executives to look for the next area of growth.

展开>> 收起<<

请登录，再发表你的看法

谢文晓

关注